Malignant signature may help identify patients likely to respond to therapy
Sunday, September 6, 2009 - 13:49
in Health & Medicine
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug.